New Study Provides Insights into the Biocompatibility and Durability of the UroLift® System in Improving Benign Prostatic Hyperplasia Symptoms
August 30, 2021
WAYNE, Pa., August 20, 2021 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today announced the publication of clinical data for the UroLift®...
Read MoreLargest U.S. Healthcare Claims and Utilization Analysis for BPH Procedures Reveals Lowest Overall Complication Rates and Consistent Durability after Treatment with Minimally Invasive UroLift System
July 9, 2021
Real-World Claims Data Presented at Annual European Association of Urology Congress Reveal Overall Complication Rates are Lowest after Treatment with...
Read MoreTeleflex Announces Real-World Clinical Data Presentations of the UroLift® System at the 36th Annual European Association of Urology Congress
July 6, 2021
Presentations to Provide New Insights on the Real-World Effectiveness and Durability of Leading Minimally Invasive Procedure for Enlarged Prostate
Read MoreNew Data Suggest Men with Urinary Symptoms Often Anticipate Bathroom Needs and Avoid Events and Activities They Enjoy
June 16, 2021
Teleflex survey finds “extreme bathroom planning” to accommodate urinary symptoms common with an enlarged prostate (BPH) impacts daily activities
Read MoreTeleflex Reports 250,000 Patients Treated for Enlarged Prostate With the Minimally Invasive UroLift® System
March 9, 2021
WAYNE, Pa., March 9, 2021 (GLOBE NEWSWIRE) – Teleflex Incorporated (NYSE: TFX) today announced that, globally, 250,000 patients have been treated...
Read MorePublished Data Demonstrate Sexual Function Improvement and Preservation with the Minimally Invasive UroLift® System Compared to Medications Prescribed for Benign Prostatic Hyperplasia
January 20, 2021
WAYNE, Pa.— January 20, 2021—Teleflex Incorporated (NYSE: TFX) announced today that new data published in the peer-reviewed journal, European Urology...
Read MoreResearch Reinforcing the Effectiveness and Safety of the UroLift® System in the Real-World Setting Presented at 50th Annual ICS Meeting
November 19, 2020
New Findings Show UroLift System Same-Day Outpatient Procedure Demonstrates Symptom Improvement for Benign Prostatic Hyperplasia
Read MoreTeleflex Interventional Urology Expands Portfolio with Introduction of the UroLift® Advanced Tissue Control (ATC)™ System
October 28, 2020
WAYNE, Pa., – October 28 2020 – Teleflex Incorporated (NYSE: TFX) today announced the expansion of its UroLift® System portfolio with the...
Read MoreTeleflex Announces 200,000 Patients Treated with UroLift System for Enlarged Prostate
July 30, 2020
Minimally Invasive, Same-Day Outpatient Procedure Provides Rapid Symptom Relief and Recovery
Read MoreTeleflex Announces Positive Data Emphasizing the Effectiveness of the UroLift® System Treatment for Enlarged Prostate Across Broad Patient Populations
July 21, 2020
Data Presented at European Association of Urology Highlights Safety and Versatility of the Minimally Invasive UroLift System in a Real-World Setting
Read More
